Trademark Overview
On Thursday, October 20, 2022, a trademark application was filed for CURECOIN with the United States Patent and Trademark Office. The USPTO has given the CURECOIN trademark a serial number of 97641316. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, November 8, 2023. This trademark is owned by National Resilience, Inc.. The CURECOIN trademark is filed in the Treatment & Processing of Materials Services, Insurance & Financial Services, and Computer & Software Services & Scientific Services categories with the following description:
Custom manufacturing of pharmaceuticals, biological preparations, chemical preparations, and reagents for others; Biomanufacturing for others, namely, manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; Providing technical information in the field of biomanufacturing
Financial investment services; Financial exchange of virtual currency; Financial services, namely, providing a virtual currency; Financial services, namely, providing a virtual currency for use by members of an on-line community; Funds investment; Currency trading; Currency transfer services; Crowd funding services; Providing a website for investors featuring information in the field of investment of funds; Providing an interactive website featuring crowd funding services; Providing an interactive website featuring crowd funding services in the nature of accepting and administering monetary contributions; Business fundraising services; Private and public equity funding; Providing investment funding services, namely, blockchain investment services; Cryptocurrency trading services; Cryptocurrency services, namely, providing a digital currency or digital token for use by members of an on-line community; Cryptocurrency services, namely, a digital currency or digital token used to operate a...
Medical research in the field of biomanufacturing; Providing non-downloadable software relating to financial services; Providing non-downloadable software relating to business fundraising services; Providing non-downloadable software relating to crowd funding services; Providing non-downloadable software relating to cryptocurrency services; Providing non-downloadable software relating to currency trading and currency transfer services; Software as a service (SAAS) services featuring software for enabling investors to invest in, purchase, sell, market investment opportunities; Research, development, and consulting services in the field of manufacturing processes for pharmaceuticals, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; Software as a service (SAAS) services featuring non-downloadable software for use in manufacturing, order placement, order tracking, and order fulfillment; Software as a service (SAAS) services featuring non-downloadable...
